Related Experiment Video
Updated: Jul 14, 2026
10:47
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Summary
Smoking temporarily increases vein wall fibrinolytic activity, potentially due to nicotine and carbon monoxide. Long-term cessation did not alter this effect, but short-term abstinence showed a non-significant trend towards lower activity.
Area of Science:
- Vascular Biology
- Thrombosis and Hemostasis
- Cardiovascular Research
Background:
- Smoking is a major risk factor for cardiovascular diseases.
- The impact of smoking on vascular fibrinolytic activity requires further investigation.
- Vein wall fibrinolysis plays a role in blood clot dissolution.
Purpose of the Study:
- To investigate the effect of smoking on the fibrinolytic activity of vein walls.
- To compare fibrinolytic activity between smokers and nonsmokers.
- To assess the impact of short-term and long-term smoking cessation on fibrinolytic activity.
Main Methods:
- Study population: 71 heavy smokers (smoking >15g tobacco/day) and 41 nonsmokers.
- Fibrinolytic activity assessed after 12 hours of tobacco abstinence.
- Evaluated effects of 8-9 weeks of smoking cessation and acute smoking (6 cigarettes over 3 hours).
- Measured euglobulin clot lysis time and fibrinolytic activity in superficial hand veins after venous occlusion.
Main Results:
- Smokers abstaining for 12 hours showed similar fibrinolytic activity to nonsmokers.
- Long-term smoking cessation (8-9 weeks) did not significantly alter fibrinolytic activity.
- Acute smoking (6 cigarettes/3 hours) was associated with increased fibrinolytic activity in blood and superficial hand veins.
- Short-term abstinence (1 week) showed a non-significant trend towards lower fibrinolytic activity.
Conclusions:
- Acute smoking appears to increase vascular fibrinolytic activity, likely mediated by nicotine and carbon monoxide.
- Long-term smoking cessation does not seem to reverse this acute effect within the study period.
- Further research is needed to fully elucidate the complex relationship between smoking and vascular fibrinolysis.
Related Concept Videos
01:16The Respiratory System
The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
01:20Types of Step-Growth Polymers: Polyesters
The introduction of polyesters has brought major development to the textile industry. The wrinkle-free behavior of polyester blends has eliminated the need for starching and ironing clothes.
Polyesters are commonly prepared from terephthalic acid and ethylene glycol; the crude product is known as poly(ethylene terephthalate) or PET. However, polyesters are synthesized industrially by transesterification of dimethyl terephthalate with ethylene glycol at 150 °C. The two reactants and the polymer...
Polyesters are commonly prepared from terephthalic acid and ethylene glycol; the crude product is known as poly(ethylene terephthalate) or PET. However, polyesters are synthesized industrially by transesterification of dimethyl terephthalate with ethylene glycol at 150 °C. The two reactants and the polymer...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...